Language

English

Publication Date

11-2-2026

Journal

Genes Development

DOI

10.1101/gad.353690.126

PMID

42562572

PMCID

PMC13573567

PubMedCentral® Posted Date

11-1-2026

PubMedCentral® Full Text Version

Post-print

Abstract

Defective small nuclear (sn)RNAs are produced from hundreds of human snRNA pseudogenes and mutant snRNA genes associated with human developmental disorders. Machineries that prevent defective snRNAs from disrupting pre-mRNA splicing remain poorly defined. Here, we identify multiple checkpoints in snRNA biogenesis monitored by quality control machineries that subject defective snRNAs to degradation and prevent their assembly into spliceosomes. We show that variant U1 snRNAs produced from human pseudogenes, some at rates approaching canonical snRNAs, are impaired in 3' cleavage and targeted for degradation by the NEXT-exosome while failures in subsequent protein assembly steps promote NEXT-exosome- or terminal uridylyl transferase 4/7-mediated degradation. These pathways also repress mutant snRNAs associated with human developmental disorders. Impeding snRNA quality control causes formation of aberrant spliceosomes and altered pre-mRNA splicing. These findings define checkpoints in snRNA biogenesis that safeguard pre-mRNA splicing and represent potential therapeutic targets for human disorders associated with snRNA mutations.

Keywords

RNA, Small Nuclear, Spliceosomes, Humans, RNA Splicing, Pseudogenes, RNA Precursors, RNA Stability, Mutation, Integrator, NEXT–exosome, RNA quality control, TUT4, TUT7, neurodevelopmental disorders (NDD), pseudogenes, snRNA, spliceosome, splicing

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.